NeuroPace (NPCE) Total Liabilities (2020 - 2026)

NeuroPace's Total Liabilities history runs 7 years deep, the most recent figure standing at $84.4 million for Q1 2026.

• On a quarterly basis, Total Liabilities fell 1.74% year-over-year to $84.4 million in Q1 2026; TTM through Mar 2026 was $84.4 million, a 1.74% decrease from a year earlier, with the FY2025 full-year figure at $86.5 million, changed 0.12% from the prior year.
• Total Liabilities fell to $84.4 million in Q1 2026 per NPCE's latest filing, from $86.5 million in the prior quarter.
• Across five years, Total Liabilities topped out at $88.7 million in Q3 2025 and bottomed at $65.6 million in Q2 2022.
• The 5-year median for Total Liabilities is $84.5 million (2024), against an average of $81.9 million.
• Across the five-year window, Total Liabilities jumped 32.09% in 2022 and declined 1.74% in 2026, its largest moves.
• Year by year, Total Liabilities stood at $79.3 million in 2022, then gained by 9.67% to $87.0 million in 2023, then retreated by 0.42% to $86.6 million in 2024, then dropped by 0.12% to $86.5 million in 2025, then dropped by 2.42% to $84.4 million in 2026.
• Per Business Quant, the three latest NPCE Total Liabilities figures stand at $84.4 million (Q1 2026), $86.5 million (Q4 2025), and $88.7 million (Q3 2025).